Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 Jul 2001

Kimura H, Miyazaki R, Suzuki S, Gejyo F, Yoshida H

Abstract excerpt

Cholesteryl ester transfer protein (CETP) may promote reverse cholesterol transport. An elevated concentration of high-density lipoprotein cholesterol (HDL-C) is a protective factor against atherosclerosis. However, the effects of CETP itself and its interaction with HDL-C have not been investigated in hemodialysis patients, who are at high risk for atherosclerosis and generally considered to have decreased...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteriosclerosis
Share to Cholesterol Ester Transfer Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, HDL

Share to Coronary Disease

Share to Glycoproteins

Share to Kidney Failure, Chronic

Share to Renal Dialysis

Share to Vascular Diseases

Source

Identifiers

PMID: 11431184
DOI: 10.1053/ajkd.2001.25196

Genes

CETP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients.PMID 11431184Read ↗

[Risk factors for atherosclerotic vascular disease in patients on maintenance hemodialysis--with especial respect to reverse cholesterol transport system and hyperhomocysteinemia].Semantic proximity Read ↗

A cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients.Semantic proximity Read ↗

Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels.Semantic proximity Read ↗

A common mutation of cholesteryl ester transfer protein gene in dialysis patients.Semantic proximity Read ↗

Cholesteryl ester transfer protein, high density lipoprotein and arterial disease.Semantic proximity Read ↗

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.Semantic proximity Read ↗

Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.Semantic proximity Read ↗

Elevated TG/HDL-C and Non-HDL-C/HDL-C Ratios Predict Mortality in Peritoneal Dialysis PatientsSemantic proximity Read ↗

Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease.Semantic proximity Read ↗

Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients.Semantic proximity Read ↗

Candidate Gene Analysis of Mortality in Dialysis Patients.Semantic proximity Read ↗

Association between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Mortality in Maintenance Haemodialysis PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.